These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3111667)

  • 1. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
    Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
    Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
    Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
    Gennari C; Imbimbo B; Montagnani M; Bernini M; Nardi P; Avioli LV
    Calcif Tissue Int; 1984 May; 36(3):245-52. PubMed ID: 6432287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
    Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
    Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
    LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
    Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prednisone and deflazacort on vertebral bone mass.
    Gennari C; Imbimbo B
    Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with a new glucocorticoid: effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.
    Ferraris JR; Pasqualini T
    J Rheumatol Suppl; 1993 Apr; 37():43-6. PubMed ID: 8501752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
    Ferraris JR; Pasqualini T; Legal S; Sorroche P; Galich AM; Pennisi P; Domene H; Jasper H
    Pediatr Nephrol; 2000 Jul; 14(7):682-8. PubMed ID: 10912543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure.
    Rutter MM; Collins J; Rose SR; Woo JG; Sucharew H; Sawnani H; Hor KN; Cripe LH; Wong BL
    Neuromuscul Disord; 2012 Dec; 22(12):1046-56. PubMed ID: 22967789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation.
    Ferraris JR; Fainstein Day P; Gutman R; Granillo E; Ramirez J; Ruiz S; Pasqualini T
    J Pediatr; 1992 Nov; 121(5 Pt 1):809-13. PubMed ID: 1432436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
    Chesney RW; Mazess RB; Rose P; Jax DK
    Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.